Skip to main content
Erschienen in: European Journal of Nutrition 1/2021

29.04.2020 | Original Contribution

Alleviation effects of Bifidobacterium breve on DSS-induced colitis depends on intestinal tract barrier maintenance and gut microbiota modulation

verfasst von: Yang Chen, Yan Jin, Catherine Stanton, R. Paul Ross, Jianxin Zhao, Hao Zhang, Bo Yang, Wei Chen

Erschienen in: European Journal of Nutrition | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The study aimed to investigate the discrepancy and potential mechanisms of different CLA-producing B. breve on dextran sulphate sodium (DSS)-induced colitis.

Methods

Colitis was induced in C57BL/6 J mice using DSS. Disease activity index (DAI), histopathological changes, epithelial barrier integrity and epithelial apoptosis were determined. Gut microbiota were gauged to evaluate the systemic effects of CLA-producing B. breve.

Results

Oral administration of different B. breve showed different effects, in which B. breve M1 and B. breve M2 alleviated the inflammation induced by DSS as well as significantly increased the concentration of mucin2 (MUC2) and goblet cells, but neither B. breve M3 nor B. breve M4 had those protective effects. Meanwhile, B. breve M1 and B. breve M2 treatments significantly up-regulated the tight junction (TJ) proteins and ameliorated the epithelial apoptosis lead by DSS challenge. Moreover, inflammatory cytokines (TNF-α, IL-6) were modulated by B. breve M1 and B. breve M2, neither B. breve M3 nor B. breve M4. Furthermore, B. breve M1 and B. breve M2 reduced the abundance of Bacteroides and increased the abundance of Odoribacter, then rebalanced the damaged gut microbiota. Colonic CLA concentrations in mice fed with B. breve M1, B. breve M2, B. breve M3 and B. breve M4 decreased successively, which showed significant positive correlation with the effectiveness of relieving colitis.

Conclusions

Bifidobacterium breve M1 and B. breve M2 alleviated DSS-induced colitis by producing CLA, inhibiting the inflammatory cytokines, maintaining of the intestinal epithelial barrier and regulating the gut microbiota.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Molodecky NA, Soon S, Rabi DM, Ghali WA, Ferris M, Chernoff G et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46–54PubMed Molodecky NA, Soon S, Rabi DM, Ghali WA, Ferris M, Chernoff G et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46–54PubMed
2.
Zurück zum Zitat Sairenji T, Collins KL, Evans DV (2017) An update on inflammatory bowel disease. Prim Care 44:673–692PubMed Sairenji T, Collins KL, Evans DV (2017) An update on inflammatory bowel disease. Prim Care 44:673–692PubMed
3.
Zurück zum Zitat Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12:S3–S9PubMed Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12:S3–S9PubMed
4.
Zurück zum Zitat Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017) Ulcerative colitis. Lancet 389:1756–1770 Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017) Ulcerative colitis. Lancet 389:1756–1770
5.
Zurück zum Zitat Green JR, Lobo AJ, Holdsworth CD, Leicester RJ, Gibson JA, Kerr GD et al (1998) Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. Gastroenterology 114:15–22PubMed Green JR, Lobo AJ, Holdsworth CD, Leicester RJ, Gibson JA, Kerr GD et al (1998) Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. Gastroenterology 114:15–22PubMed
6.
Zurück zum Zitat Pearson C (2004) Inflammatory bowel disease. Clin Adv Nutr 100:86–90 Pearson C (2004) Inflammatory bowel disease. Clin Adv Nutr 100:86–90
7.
Zurück zum Zitat Osman N, Adawi D, Molin G, Ahrne S, Berggren A, Jeppsson B (2006) Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol 6:6–31 Osman N, Adawi D, Molin G, Ahrne S, Berggren A, Jeppsson B (2006) Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol 6:6–31
8.
Zurück zum Zitat Bassaganya-Riera J, Hontecillas R (2006) CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin Nutr 25:454–465PubMed Bassaganya-Riera J, Hontecillas R (2006) CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin Nutr 25:454–465PubMed
9.
Zurück zum Zitat Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F (2004) Hontecillas, Activation of PPAR [gamma] and [delta] by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127:777–791PubMed Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F (2004) Hontecillas, Activation of PPAR [gamma] and [delta] by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127:777–791PubMed
10.
Zurück zum Zitat Clément L, Poirier H, Niot I, Bocher V, Guerre-Millo M, Krief S et al (2002) Dietary trans-10, cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 43:1400–1409PubMed Clément L, Poirier H, Niot I, Bocher V, Guerre-Millo M, Krief S et al (2002) Dietary trans-10, cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 43:1400–1409PubMed
11.
Zurück zum Zitat Kelley DS, Bartolini GL, Warren JM, Simon VA, Mackey BE, Erickson KL (2004) Contrasting effects of t10, c12- and c9, t11-conjugated linoleic acid isomers on the fatty acid profiles of mouse liver lipids. Lipids 39:135–141PubMed Kelley DS, Bartolini GL, Warren JM, Simon VA, Mackey BE, Erickson KL (2004) Contrasting effects of t10, c12- and c9, t11-conjugated linoleic acid isomers on the fatty acid profiles of mouse liver lipids. Lipids 39:135–141PubMed
12.
Zurück zum Zitat Jaudszus A, Moeckel P, Hamelmann E, Jahreis G (2010) Trans-10, cis-12-CLA-caused lipodystrophy is associated with profound changes of fatty acid profiles of liver, white adipose tissue and erythrocytes in mice: possible link to tissue-specific alterations of fatty acid desaturation. Ann Nutr Metab 57:103–111PubMed Jaudszus A, Moeckel P, Hamelmann E, Jahreis G (2010) Trans-10, cis-12-CLA-caused lipodystrophy is associated with profound changes of fatty acid profiles of liver, white adipose tissue and erythrocytes in mice: possible link to tissue-specific alterations of fatty acid desaturation. Ann Nutr Metab 57:103–111PubMed
13.
Zurück zum Zitat Takahashi Y, Kushiro M, Shinohara K, Ide T (2003) Activity and mRNA levels of enzymes involved in hepatic fatty acid synthesis and oxidation in mice fed conjugated linoleic acid. BBA-Mol Cell Biol L 1631:265–273 Takahashi Y, Kushiro M, Shinohara K, Ide T (2003) Activity and mRNA levels of enzymes involved in hepatic fatty acid synthesis and oxidation in mice fed conjugated linoleic acid. BBA-Mol Cell Biol L 1631:265–273
14.
Zurück zum Zitat Rasooly R, Kelley DS, Greg J, Mackey BE, Belury MA, Belury MA et al (2007) Dietary trans 10, cis 12-conjugated linoleic acid reduces the expression of fatty acid oxidation and drug detoxification enzymes in mouse liver. Brit J Nutr 97:58–66PubMed Rasooly R, Kelley DS, Greg J, Mackey BE, Belury MA, Belury MA et al (2007) Dietary trans 10, cis 12-conjugated linoleic acid reduces the expression of fatty acid oxidation and drug detoxification enzymes in mouse liver. Brit J Nutr 97:58–66PubMed
15.
Zurück zum Zitat Coakley M, Ross RP, Nordgren M, Fitzgerald G, Devery R, Stanton C (2003) Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species. J Appl Microbiol 94:138–145PubMed Coakley M, Ross RP, Nordgren M, Fitzgerald G, Devery R, Stanton C (2003) Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species. J Appl Microbiol 94:138–145PubMed
16.
Zurück zum Zitat Chung SH, Kim IH, Park HG, Kang HS, Yoon CS, Jeong HY et al (2008) Synthesis of conjugated linoleic acid by human-derived Bifidobacterium breve LMC 017: utilization as a functional starter culture for milk fermentation. J Agric Food Chem 56:3311–3316PubMed Chung SH, Kim IH, Park HG, Kang HS, Yoon CS, Jeong HY et al (2008) Synthesis of conjugated linoleic acid by human-derived Bifidobacterium breve LMC 017: utilization as a functional starter culture for milk fermentation. J Agric Food Chem 56:3311–3316PubMed
17.
Zurück zum Zitat Kepler CR, Tucker WP, Tove SB (1971) Biohydrogenation of unsaturated fatty acids. V. Stereospecificity of proton addition and mechanism of action of linoleic acid Δ12-cis, Δ11-trans-isomerase from Butyrivibrio fibrisolvens. J Biol Chem 246:2765–2771PubMed Kepler CR, Tucker WP, Tove SB (1971) Biohydrogenation of unsaturated fatty acids. V. Stereospecificity of proton addition and mechanism of action of linoleic acid Δ12-cis, Δ11-trans-isomerase from Butyrivibrio fibrisolvens. J Biol Chem 246:2765–2771PubMed
18.
Zurück zum Zitat Raimondi S, Amaretti A, Leonardi A, Quartieri A, Gozzoli C, Rossi M (2016) Conjugated linoleic acid production by bifidobacteria: screening, kinetic, and composition. Biomed Res Int 2016:1–9 Raimondi S, Amaretti A, Leonardi A, Quartieri A, Gozzoli C, Rossi M (2016) Conjugated linoleic acid production by bifidobacteria: screening, kinetic, and composition. Biomed Res Int 2016:1–9
19.
Zurück zum Zitat Wang J, Chen H, Yang B, Gu Z, Zhang H, Chen W et al (2016) Lactobacillus plantarum ZS2058 produces CLA to ameliorate DSS-induced acute colitis in mice. RSC Adv 6:14457–14464 Wang J, Chen H, Yang B, Gu Z, Zhang H, Chen W et al (2016) Lactobacillus plantarum ZS2058 produces CLA to ameliorate DSS-induced acute colitis in mice. RSC Adv 6:14457–14464
20.
Zurück zum Zitat Yang B, Chen H, Gao H, Wang J, Stanton C, Ross RP et al (2018) Bifidobacterium breve CCFM683 could ameliorate DSS-induced colitis in mice primarily via conjugated linoleic acid production and gut microbiota modulation. J Funct Foods 49:61–72 Yang B, Chen H, Gao H, Wang J, Stanton C, Ross RP et al (2018) Bifidobacterium breve CCFM683 could ameliorate DSS-induced colitis in mice primarily via conjugated linoleic acid production and gut microbiota modulation. J Funct Foods 49:61–72
21.
Zurück zum Zitat Yang B, Chen H, Gu Z, Tian F, Ross RP, Stanton C et al (2014) Synthesis of conjugated linoleic acid by the linoleate isomerase complex in food-derived lactobacilli. J Appl Microbiol 117:430–439PubMedPubMedCentral Yang B, Chen H, Gu Z, Tian F, Ross RP, Stanton C et al (2014) Synthesis of conjugated linoleic acid by the linoleate isomerase complex in food-derived lactobacilli. J Appl Microbiol 117:430–439PubMedPubMedCentral
22.
Zurück zum Zitat Fang Z, Li L, Liu X, Lu W, Zhao J, Zhang H et al (2019) Strain-specific ameliorating effect of Bifidobacterium longum on atopic dermatitis in mice. J Funct Foods 60:103426 Fang Z, Li L, Liu X, Lu W, Zhao J, Zhang H et al (2019) Strain-specific ameliorating effect of Bifidobacterium longum on atopic dermatitis in mice. J Funct Foods 60:103426
23.
Zurück zum Zitat Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N et al (2009) Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol-Gastr L 296:G1140–G1149 Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N et al (2009) Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol-Gastr L 296:G1140–G1149
24.
Zurück zum Zitat Murthy SNS, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ (1993) Treatment of dextran sulfate sodium-induced murine colitis by intra colonic cyclosporine. Digest Dis Sci 38:1722–1734PubMed Murthy SNS, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ (1993) Treatment of dextran sulfate sodium-induced murine colitis by intra colonic cyclosporine. Digest Dis Sci 38:1722–1734PubMed
25.
Zurück zum Zitat Rees V (1998) Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114:385–391PubMed Rees V (1998) Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114:385–391PubMed
26.
Zurück zum Zitat Steedman HF (1950) Alcian blue 8GS: a new stain for mucin. J Cell Sci 91:477–479 Steedman HF (1950) Alcian blue 8GS: a new stain for mucin. J Cell Sci 91:477–479
27.
Zurück zum Zitat Wu H, Ye L, Lu X, Xie S, Yang Q, Yu Q (2018) Lactobacillus acidophilus alleviated Salmonella-induced goblet cells loss and colitis by Notch pathway. Mol Nutr Food Res 62:1800552 Wu H, Ye L, Lu X, Xie S, Yang Q, Yu Q (2018) Lactobacillus acidophilus alleviated Salmonella-induced goblet cells loss and colitis by Notch pathway. Mol Nutr Food Res 62:1800552
28.
Zurück zum Zitat Tan GX, Wang XN, Tang YY, Cen WJ, Li ZH, Wang GC et al (2019) PP22 promotes autophagy and apoptosis in the nasopharyngeal carcinoma cell line CNE-2 by inducing endoplasmic reticulum stress, down regulating STAT3 signaling, and modulating the MAPK pathway. J Cell Physiol 234:2618–2630PubMed Tan GX, Wang XN, Tang YY, Cen WJ, Li ZH, Wang GC et al (2019) PP22 promotes autophagy and apoptosis in the nasopharyngeal carcinoma cell line CNE-2 by inducing endoplasmic reticulum stress, down regulating STAT3 signaling, and modulating the MAPK pathway. J Cell Physiol 234:2618–2630PubMed
29.
Zurück zum Zitat Classics Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917 Classics Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917
30.
Zurück zum Zitat Schwenke DC (2002) Alpha-tocopherol protects against diet induced atherosclerosis in New Zealand white rabbits. J Lipid Res 43:1927–1938PubMed Schwenke DC (2002) Alpha-tocopherol protects against diet induced atherosclerosis in New Zealand white rabbits. J Lipid Res 43:1927–1938PubMed
31.
Zurück zum Zitat Yang Q, Wang S, Ji Y, Chen H, Zhang H, Chen W et al (2017) Dietary intake of n-3 PUFAs modifies the absorption, distribution and bioavailability of fatty acids in the mouse gastrointestinal tract. Lipids Health Dis 16:10PubMedPubMedCentral Yang Q, Wang S, Ji Y, Chen H, Zhang H, Chen W et al (2017) Dietary intake of n-3 PUFAs modifies the absorption, distribution and bioavailability of fatty acids in the mouse gastrointestinal tract. Lipids Health Dis 16:10PubMedPubMedCentral
32.
Zurück zum Zitat Yan S, Yang B, Zhao J, Zhao J, Stanton C, Ross RP et al (2019) A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. Food Funct 10:1595–1608PubMed Yan S, Yang B, Zhao J, Zhao J, Stanton C, Ross RP et al (2019) A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. Food Funct 10:1595–1608PubMed
33.
Zurück zum Zitat Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M (2014) Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol 104:15–25PubMed Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M (2014) Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol 104:15–25PubMed
34.
Zurück zum Zitat Zwolinska-Wcislo M, Brzozowski T, Ptak-Belowska A, Targosz A, Urbanczyk K, Kwiecien S et al (2011) Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis. World J Gastroenterol 17:4076–4089PubMedPubMedCentral Zwolinska-Wcislo M, Brzozowski T, Ptak-Belowska A, Targosz A, Urbanczyk K, Kwiecien S et al (2011) Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis. World J Gastroenterol 17:4076–4089PubMedPubMedCentral
35.
Zurück zum Zitat Xing J, You C, Dong K, Sun J, You H, Dong Y et al (2013) Ameliorative effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in rats. Int Immunopharmacol 15:524–531PubMed Xing J, You C, Dong K, Sun J, You H, Dong Y et al (2013) Ameliorative effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in rats. Int Immunopharmacol 15:524–531PubMed
36.
Zurück zum Zitat Peterson LW, Artis D (2014) Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 14:141–153PubMed Peterson LW, Artis D (2014) Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 14:141–153PubMed
37.
Zurück zum Zitat Kim YS, Ho SB (2010) Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep 12:319–330PubMedPubMedCentral Kim YS, Ho SB (2010) Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep 12:319–330PubMedPubMedCentral
38.
Zurück zum Zitat Hansson GC (2012) Role of mucus layers in gut infection and inflammation. Curr Opin Microbio 15:57–62 Hansson GC (2012) Role of mucus layers in gut infection and inflammation. Curr Opin Microbio 15:57–62
39.
Zurück zum Zitat Van Klinken BJ, Van der Wal JW, Einerhand AW, Buller HA, Dekker J (1999) Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut 44:387–393PubMedPubMedCentral Van Klinken BJ, Van der Wal JW, Einerhand AW, Buller HA, Dekker J (1999) Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut 44:387–393PubMedPubMedCentral
40.
Zurück zum Zitat Theodoratou E, Campbell H, Ventham NT, Kolarich D, Pucic-Bakovic M, Zoldos V et al (2014) The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol 11:588–600PubMed Theodoratou E, Campbell H, Ventham NT, Kolarich D, Pucic-Bakovic M, Zoldos V et al (2014) The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol 11:588–600PubMed
41.
Zurück zum Zitat Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ et al (1999) Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116:301–309PubMed Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ et al (1999) Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116:301–309PubMed
42.
Zurück zum Zitat Shen L, Weber CR, Raleigh DR, Yu D, Turner JR (2011) Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 73:283–309PubMedPubMedCentral Shen L, Weber CR, Raleigh DR, Yu D, Turner JR (2011) Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 73:283–309PubMedPubMedCentral
43.
Zurück zum Zitat Ivanov AI, Naydenov NG (2013) Dynamics and regulation of epithelial adherens junctions: recent discoveries and controversies. Int Rev Cell Mol Biol 303:27–99PubMed Ivanov AI, Naydenov NG (2013) Dynamics and regulation of epithelial adherens junctions: recent discoveries and controversies. Int Rev Cell Mol Biol 303:27–99PubMed
44.
Zurück zum Zitat Ivanov AI, Parkos CA, Nusrat A (2010) Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol 177:512–524PubMedPubMedCentral Ivanov AI, Parkos CA, Nusrat A (2010) Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol 177:512–524PubMedPubMedCentral
45.
Zurück zum Zitat Zakostelska Z, Kverka M, Klimesova K, Rossmann P, Mrazek J, Kopecny J et al (2011) Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS ONE 6:e27961PubMedPubMedCentral Zakostelska Z, Kverka M, Klimesova K, Rossmann P, Mrazek J, Kopecny J et al (2011) Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS ONE 6:e27961PubMedPubMedCentral
46.
Zurück zum Zitat Srutkova D, Schwarzer M, Hudcovic T, Zakostelska Z, Drab V, Spanova A et al (2015) Bifidobacterium longum CCM 7952 promotes epithelial barrier function and prevents acute DSS-induced colitis in strictly strain-specific manner. PLoS ONE 10:e0134050PubMedPubMedCentral Srutkova D, Schwarzer M, Hudcovic T, Zakostelska Z, Drab V, Spanova A et al (2015) Bifidobacterium longum CCM 7952 promotes epithelial barrier function and prevents acute DSS-induced colitis in strictly strain-specific manner. PLoS ONE 10:e0134050PubMedPubMedCentral
47.
Zurück zum Zitat Wang G, Xu Q, Jin X, Hang F, Liu Z, Zhao J et al (2018) Effects of lactobacilli with different regulatory behaviours on tight junctions in mice with dextran sodium sulphate-induced colitis. J Funct Foods 47:107–115 Wang G, Xu Q, Jin X, Hang F, Liu Z, Zhao J et al (2018) Effects of lactobacilli with different regulatory behaviours on tight junctions in mice with dextran sodium sulphate-induced colitis. J Funct Foods 47:107–115
48.
Zurück zum Zitat Liu HY, Roos S, Jonsson H, Ahl D, Dicksved J, Lindberg JE et al (2015) Effects of lactobacillus johnsonii and lactobacillus reuteri on gut barrier function and heat shock proteins in intestinal porcine epithelial cells. Physiol Rep 3:e12355PubMedPubMedCentral Liu HY, Roos S, Jonsson H, Ahl D, Dicksved J, Lindberg JE et al (2015) Effects of lactobacillus johnsonii and lactobacillus reuteri on gut barrier function and heat shock proteins in intestinal porcine epithelial cells. Physiol Rep 3:e12355PubMedPubMedCentral
49.
Zurück zum Zitat Fei L, Xu K (2016) Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway. J Ethnopharmacol 192:236–247PubMed Fei L, Xu K (2016) Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway. J Ethnopharmacol 192:236–247PubMed
50.
Zurück zum Zitat Hegazy SK (2010) Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis. World J Gastroenterol 16:4145–4151PubMedPubMedCentral Hegazy SK (2010) Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis. World J Gastroenterol 16:4145–4151PubMedPubMedCentral
51.
Zurück zum Zitat Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T (2010) Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 49:1215–1228 Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T (2010) Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 49:1215–1228
52.
Zurück zum Zitat Lee IA, Bae EA, Lee JH, Lee H, Ahn YT, Huh CS et al (2010) Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice. Inflamm Res 59:359–368PubMed Lee IA, Bae EA, Lee JH, Lee H, Ahn YT, Huh CS et al (2010) Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice. Inflamm Res 59:359–368PubMed
53.
Zurück zum Zitat Jin S, Zhao D, Cai C, Song D, Shen J, Xu A et al (2017) Low-dose penicillin exposure in early life decreases Th17 and the susceptibility to DSS colitis in mice through gut microbiota modification. Sci Rep 7:43662PubMedPubMedCentral Jin S, Zhao D, Cai C, Song D, Shen J, Xu A et al (2017) Low-dose penicillin exposure in early life decreases Th17 and the susceptibility to DSS colitis in mice through gut microbiota modification. Sci Rep 7:43662PubMedPubMedCentral
54.
Zurück zum Zitat Fujio-Vejar S, Vasquez Y, Morales P, Magne F, Vera-Wolf P, Ugalde JA et al (2017) The gut microbiota of healthy Chilean subjects reveals a high abundance of the phylum Verrucomicrobia. Front Microbiol 8:1–11 Fujio-Vejar S, Vasquez Y, Morales P, Magne F, Vera-Wolf P, Ugalde JA et al (2017) The gut microbiota of healthy Chilean subjects reveals a high abundance of the phylum Verrucomicrobia. Front Microbiol 8:1–11
55.
Zurück zum Zitat Torres PJ, Siakowska M, Banaszewska B, Pawelczyk L, Duleba AJ, Kelley ST et al (2018) Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism. J Clin Endocr Metab 103:1502–1511PubMed Torres PJ, Siakowska M, Banaszewska B, Pawelczyk L, Duleba AJ, Kelley ST et al (2018) Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism. J Clin Endocr Metab 103:1502–1511PubMed
56.
Zurück zum Zitat Gomez-Arango LF, Barrett H, McIntyre D, Callaway LK, Morrison M, Nitert MD (2016) Increased systolic and diastolic blood pressure is associated with altered gut microbiota composition and butyrate production in early pregnancy. Hypertension 68:974–977PubMed Gomez-Arango LF, Barrett H, McIntyre D, Callaway LK, Morrison M, Nitert MD (2016) Increased systolic and diastolic blood pressure is associated with altered gut microbiota composition and butyrate production in early pregnancy. Hypertension 68:974–977PubMed
57.
Zurück zum Zitat Chen G, Ran X, Li B, Li Y, He D, Huang B et al (2018) Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine 30:317–325PubMedPubMedCentral Chen G, Ran X, Li B, Li Y, He D, Huang B et al (2018) Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine 30:317–325PubMedPubMedCentral
58.
Zurück zum Zitat Chen L, Sun M, Wu W, Yang W, Huang X, Xiao Y (2019) Microbiota metabolite butyrate differentially regulates Th1 and Th17 cells’ differentiation and function in induction of colitis. Inflamm Bowel Dis 25:1450–1461PubMedPubMedCentral Chen L, Sun M, Wu W, Yang W, Huang X, Xiao Y (2019) Microbiota metabolite butyrate differentially regulates Th1 and Th17 cells’ differentiation and function in induction of colitis. Inflamm Bowel Dis 25:1450–1461PubMedPubMedCentral
59.
Zurück zum Zitat Kuwahara T, Yamashita A, Hirakawa H, Nakayama H, Toh H, Okada N et al (2004) Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation. Proc Natl Acad Sci 101:14919–14924PubMed Kuwahara T, Yamashita A, Hirakawa H, Nakayama H, Toh H, Okada N et al (2004) Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation. Proc Natl Acad Sci 101:14919–14924PubMed
60.
Zurück zum Zitat Setoyama H, Imaoka A, Ishikawa H, Umesaki Y (2003) Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients. Microbes Infect 5:115–122PubMed Setoyama H, Imaoka A, Ishikawa H, Umesaki Y (2003) Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients. Microbes Infect 5:115–122PubMed
61.
Zurück zum Zitat Bamba T, Matsuda H, Endo M, Fujiyama Y (1995) The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis. J Gastroenterol 30:45–47PubMed Bamba T, Matsuda H, Endo M, Fujiyama Y (1995) The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis. J Gastroenterol 30:45–47PubMed
62.
Zurück zum Zitat Hudcovic T, Kozakova H, Kolinska J, Stepankova R, Hrncir T, Tlaskalova- Hogenova H (2009) Monocolonization with Bacteroides ovatus protects immu-nodeficient SCID mice from mortality in chronic intestinal inflammation caused by long-lasting dextran sodium sulfate treatment. Physiol Res 58:101–110PubMed Hudcovic T, Kozakova H, Kolinska J, Stepankova R, Hrncir T, Tlaskalova- Hogenova H (2009) Monocolonization with Bacteroides ovatus protects immu-nodeficient SCID mice from mortality in chronic intestinal inflammation caused by long-lasting dextran sodium sulfate treatment. Physiol Res 58:101–110PubMed
63.
Zurück zum Zitat Borniquel S, Jadert C, Lundberg JO (2012) Dietary conjugated linoleic acid activates PPARgamma and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate sodium-induced colitis. J Nutr 142:2135–2140PubMed Borniquel S, Jadert C, Lundberg JO (2012) Dietary conjugated linoleic acid activates PPARgamma and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate sodium-induced colitis. J Nutr 142:2135–2140PubMed
64.
Zurück zum Zitat Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Carbo A, Shaykhutdinov R et al (2012) Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR gamma to suppress colitis. PLoS ONE 7:e31238PubMedPubMedCentral Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Carbo A, Shaykhutdinov R et al (2012) Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR gamma to suppress colitis. PLoS ONE 7:e31238PubMedPubMedCentral
65.
Zurück zum Zitat Chen Y, Yang B, Ross RP, Jin Y, Stanton C, Zhao J et al (2019) Orally administered CLA ameliorates DSS-induced colitis in mice via intestinal barrier improvement, oxidative stress reduction, and inflammatory cytokine and gut microbiota modulation. J Agric Food Chem 67:13282–13298 Chen Y, Yang B, Ross RP, Jin Y, Stanton C, Zhao J et al (2019) Orally administered CLA ameliorates DSS-induced colitis in mice via intestinal barrier improvement, oxidative stress reduction, and inflammatory cytokine and gut microbiota modulation. J Agric Food Chem 67:13282–13298
Metadaten
Titel
Alleviation effects of Bifidobacterium breve on DSS-induced colitis depends on intestinal tract barrier maintenance and gut microbiota modulation
verfasst von
Yang Chen
Yan Jin
Catherine Stanton
R. Paul Ross
Jianxin Zhao
Hao Zhang
Bo Yang
Wei Chen
Publikationsdatum
29.04.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 1/2021
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-020-02252-x

Weitere Artikel der Ausgabe 1/2021

European Journal of Nutrition 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.